| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +33% |
| 3Y CAGR | +21% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +42% |
| 3Y CAGR | +28% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,379.90 +17.10 (0.72%) | 17,958.14 | 26.49 | 5.33 | ||
PfizerPFIZER | ₹3,781.80 +47.40 (1.27%) | 17,040.57 | 23.18 | 4.05 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,289.50 +52.50 (0.84%) | 15,586.75 | 91.89 | 17.86 | ||
Natco PharmaNATCOPHARM | ₹797.20 +4.20 (0.53%) | 15,562.98 | 13.6 | 1.48 |